LiuWeiLuoBi Granule for the Treatment of Diabetic Peripheral Neuropathy
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Based on network pharmacology, Liuweiluobi Granule was screened to treat diabetes peripheral
neuropathy with deficiency of the spleen and kidney and stasis-heat syndrome.In the
preliminary animal experiment, it suggested that this granule had a significant protective
effect on the peripheral motor nerves of diabetic peripheral neuropathy and the effect of
anti-inflammation, and the prescription did not induce the death of zebrafish at a
concentration of 1000 ug/mL, without any obvious toxicity. This study aims to evaluate the
efficacy of Liuweiluobi Granule in improving neurotransmission function in patients with
diabetic peripheral neuropathy through a pilot, randomized controlled study.